REPLICA announces its third Harmonization Meeting
The REPLICA Project is proud to announce the third Harmonization meeting involving researchers and international partners. The two-day session is going to be held on May 26 and May 28 2021
Replica (CoEHAR): is there any correlation between Covid-19 and Harm Reduction?
A new study by CoEHAR, the "Role of Cigarette Smoke on Angiotensin-Converting Enzyme-2 Protein Membrane Expression in Bronchial Epithelial Cells Using an Air-Liquid Interface Model" investigates the molecular mechanisms that regulate the expression of the ACE2 enzyme, involved in Covid-19 infection
Replica Project: a new study sets quality standards for the storage conditions of nicotine samples
The new study by CoEHAR, "Nicotine dosimetry and stability in cambridge filter PADs (CFPs) following different smoking regime protocols and storage conditions", provided new guidelines for future multicentric studies in the low-risk products
Latest study by CoEHAR aims to systematically review all the studies on health effects of e-cigarette substitution
The main goal of the protocol, the research project plan, is to examine the scientific evidence on the effects of e-cigarettes on smokers from the available studies. The project includes writing a paper for doctors and health care providers, a fact sheet for people who use e-cigarettes, and a policy brief for legislators on health committees
Fourth leading cause of death globally (COPD): smoking cessation new research
A significant new three-year independent study on COPD and smoking has been released by the CoEHAR of the University of Catania (Italy), led by Professor Riccardo Polosa
Electronic cigarettes help smokers with schizophrenia quit
A new study in Nicotine & Tobacco Research, published by Oxford University Press, finds that the use of high-strength nicotine e-cigarettes can help adults with schizophrenia spectrum disorders quit smoking
CoEHAR- The risk of Covid-19 transmission with vaping is negligible, equal to 1%
According to the latest study by COEHAR laboratories within the University of Catania, conducted by a group coordinated by Professor Riccardo Polosa, the risk of Covid-19 transmission with vaping is negligible, equal to 1%
International Meeting on Catania Conversation discussed Public Health and future opportunities for 2021
"Vaping and COVID19: What are some of the key scientific learnings for public health and vaping as we prepare for 2021? What can we do better from patients’ perspectives?" the title of the event of last 16th December, where some of the most important names in the field of Harm Reduction discussed different topics, including the Public Health Response to the Covid-19 pandemic
New CoEHAR study evaluates the relation between Covid-19 and e-cigarette
The e-cigarette aerosol foster the transmission of the SARS-CoV-2 virus? According to the research, vaping add 1% risk to the already existing risks from breathing indoor
Vaping: The sensory experience that improves your chances to quit smoking
Vaping has revealed effective where official therapies failed. What is the secret of its success? A study by researchers Di Piazza, Caponnetto, Askin, Christos, Maglia, Gautam, Roche and Polosa tries to explain the reasons behind its success. The results are on the prestigious international Harm Reduction Journal.
